Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

RESMED INC Director's Dealing 2016

Nov 14, 2016

30071_dirs_2016-11-14_5a344a89-0705-4cad-8e41-6d7595406ee1.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: RESMED INC (RMD)
CIK: 0000943819
Period of Report: 2016-11-11

Reporting Person: Farrell Michael J. (Chief Executive Officer)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2016-11-11 ResMed Common Stock F 6469 $59.85 Disposed 191653 Direct
2016-11-11 ResMed Common Stock F 8685 $59.85 Disposed 182968 Direct
2016-11-11 ResMed Common Stock F 8518 $59.85 Disposed 174450 Direct

Footnotes

F1: Disposition to issuer for tax withholding upon vesting of performance-based Restricted Stock Units granted on 11/13/2013.

F2: Includes 316 shares of ResMed stock purchased on 10/31/2016, through the ResMed Employee Stock Purchase Plan.

F3: Disposition to issuer for tax withholding upon vesting of performance-based Restricted Stock Units granted on 11/19/2014.

F4: Disposition to issuer for tax withholding upon vesting of performance-based Restricted Stock Units granted on 11/19/2015.